Skip to main content

Closed

ENVB: Enveric Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-162.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-12000.1×

Current ratio11.67×

Enveric Biosciences, Inc.

ENVBNASDAQ Capital Market·USD·Closed

Enveric Biosciences, Inc.

ENVBNASDAQ·USD·Closed

$1.57

+9.79%

$1.57

+$0.14 (9.79%)

52W Range

2thpctl

Volume

0.35×avg

Mkt Cap

937309USD

P/E

-0.1TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.35×avg

Market Cap

937309USD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings